Hostname: page-component-76fb5796d-x4r87 Total loading time: 0 Render date: 2024-04-26T06:34:30.473Z Has data issue: false hasContentIssue false
  • English
  • Français

Cognitive reserve and neuropsychological functioning in patients infected with hepatitis C

Published online by Cambridge University Press:  18 May 2007

LINAS A. BIELIAUSKAS ,
CARLA BACK-MADRUGA ,
KAREN L. LINDSAY ,
ELIZABETH C. WRIGHT ,
ZIAD KRONFOL ,
ANNA S.F. LOK  and
ROBERT J. FONTANA
LINAS A. BIELIAUSKAS
Affiliation:
Neuropsychology Section, Department of Psychiatry, University of Michigan Medical Center, Ann Arbor, Michigan Psychology Service, Veterans Affairs Healthcare System, Ann Arbor, Michigan
CARLA BACK-MADRUGA
Affiliation:
Department of Psychiatry and the Behavioral Sciences, University of Southern California, Los Angeles, California
KAREN L. LINDSAY
Affiliation:
Division of Gastrointestinal and Liver Diseases, Keck School of Medicine, University of Southern California, Los Angeles, California
ELIZABETH C. WRIGHT
Affiliation:
New England Research Institutes, Watertown, Massachusetts Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland
ZIAD KRONFOL
Affiliation:
Neuropsychology Section, Department of Psychiatry, University of Michigan Medical Center, Ann Arbor, Michigan
ANNA S.F. LOK
Affiliation:
Division of Gastroenterology, University of Michigan Medical Center, Ann Arbor, Michigan
ROBERT J. FONTANA
Affiliation:
Division of Gastroenterology, University of Michigan Medical Center, Ann Arbor, Michigan
Get access Rights & Permissions [Opens in a new window]

Abstract

This study evaluated the influence of cognitive reserve on neuropsychological test performance in 198 patients infected with the hepatitis C virus. IQ scores, educational level, and occupational rating were combined to calculate a Cognitive Reserve Score (CRS) for each patient. Similar to studies of infection with the human immunodeficiency virus, there was a significantly increased risk of impairment in neuropsychological test performance in individuals with lower CRSs. It is important to account for CRS when assessing cognitive findings in large-scale clinical trials. (JINS, 2007, 13, 687–692.)Financial relationships of the authors with Hoffmann-La Roche, Inc., are as follows: K.L. Lindsay is a consultant and receives research support; A.S.F. Lok is a consultant and receives grant support; and R.J. Fontana is on the speaker's bureau. Authors with no financial relationships related to this project are as follows: L.A. Bieliauskas, C. Back-Madruga, E.C. Wright, and Z. Kronfol.

Keywords

Liver diseasesHepatic insufficiencyIntelligenceIQCognitive manifestationsNeurobehavioral manifestations
Type
BRIEF COMMUNICATION
Information
Journal of the International Neuropsychological Society , Volume 13 , Issue 4 , July 2007 , pp. 687 - 692
Copyright
© 2007 The International Neuropsychological Society

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Alexander, G., Furey, M., Grady, C., Pietrini, P., Brady, D.R., Mentis, M.J., & Schapiro, M.B. (1997). Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: Implications for the cognitive reserve hypothesis. American Journal of Psychiatry, 154, 165–172.Google Scholar
Axelrod, B.N. & Wall, J.R. (2003). Specificity of the Halstead-Reitan Neuropsychological Test Battery. Presented at the 111th Annual Meeting of the American Psychological Association, Toronto, Canada. The Clinical Neuropsychologist, 17, 101.Google Scholar
Barona, A., Reynolds, C.R., & Chastain, R. (1984). A demographically based index of premorbid intelligence for the WAIS-R. Journal of Consulting and Clinical Psychology, 52, 885–887.Google Scholar
Basso, M. & Bornstein, R. (2000). Estimated premorbid intelligence mediates neurobehavioral change in individuals infected with HIV across 12 months. Journal of Clinical and Experimental Neuropsychology, 22, 208–218.Google Scholar
Bieliauskas, L.A., Back-Madruga, C., Lindsay, K.L., Snow, K.K., Kronfol, Z., Lok, A.S., Padmanabhan, L., Fontana, R.J., & the HALT-C Trial Group. (2006). Clinical relevance of cognitive scores in hepatitis C patients with advanced fibrosis. Journal of Clinical and Experimental Neuropsychology, 28, 1346–1361.Google Scholar
Bieliauskas, L.A., Depp, C., Kauszler, M.L., Steinberg, B.A., & Lacy, M. (2000). IQ and scores on the Mini-Mental State Examination (MMSE). Aging, Neuropsychology, and Cognition, 7, 227–229.Google Scholar
DeLong, E.R., Delong, D.M., & Clarke-Pearson, D.L. (1988). Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics, 44, 837–845.Google Scholar
Dodrill, C.B. (1997). Myths of neuropsychology. The Clinical Neuropsychologist, 11, 1–17.Google Scholar
Fontana, R.J., Bieliauskas, L.A., Back-Madruga, C., Lindsay, K.L., Kronfol, A., Lok, A.S., Padmanabhan, L., & the HALT-C Trial Group. (2005). Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial. Journal of Hepatology, 43, 614–622.Google Scholar
Heaton, R.K., Kirson, D., Velin, R.A., Grant, I., & The HNRC Group (1994). The utility of clinician ratings for detecting cognitive change in HIV infection. In I. Grant & A. Martin (Eds.), Neuropsychology of HIV infection (pp. 188–206). New York: Oxford.
Hosmer, D.W. & Lemeshow, S. (1989). Applied logistic regression. New York: John Wiley & Sons.
Humphreys, L.G. (1962). The organization of human abilities. American Psychologist, 17, 475–483.Google Scholar
Humphreys, L.G. (1976–1977). Theory of intelligence and the management of classroom learning. Interchange, 7, 45–50.Google Scholar
Humphreys, L.G. (1979). The construct of general intelligence. Intelligence, 3, 105–120.Google Scholar
Lee, W.M., Dienstag, J.L., Lindsay, K.L., Lok, A.S., Bonkovsky, H.L., Shiffman, M.L., Everson, G.T., Di Bisceglie, A.M., Morgan, T.R., Ghany, M.G., Morishima, C., Wright, E.C., Everhart, J.E., & the HALT-C Trial Group. (2004). Evolution of the HALT-C trial: Pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders—The HALT-C Group. Controlled Clinical Trials, 25, 472–492.Google Scholar
Lezak, M.D. (1988). IQ: R.I.P. Journal of Clinical and Experimental Neuropsychology, 10, 351–361.Google Scholar
Satz, P. (1993). Brain reserve capacity on symptoms onset after brain injury: A formulation and review of evidence for Threshold Theory. Neuropsychology, 7, 273–295.Google Scholar
Satz, P., Morgenstern, H., Miller, E.N., Selnes, O.A., McArthur, J.C., Cohen, B.A., Wesch, J., Becker, J.T., Jacobson, L., D'Elia, L.F., van Gorp, W., & Visscher, B. (1993). Low education as a possible risk factor for early cognitive abnormalities in HIV-1: Findings from the Multicenter AIDS Cohort Study (MACS). Journal of Acquired Immune Deficiency Syndrome, 6, 503–511.Google Scholar
Steinberg, B.A. & Bieliauskas, L.A. (2005). Introduction to the special edition: IQ-based MOANS norms for multiple neuropsychological instruments. The Clinical Neuropsychologist, 19, 277–279.Google Scholar
Stern, Y. (2003). The concept of cognitive reserve: A catalyst for research. Journal of Clinical and Experimental Neuropsychology, 25, 589–593.Google Scholar
Stern, R.A., Silva, S.G., Chaisson, N., & Evans, D.L. (1996). Influence of cognitive reserve on neuropsychological functioning in asymptomatic human immunodeficiency virus-1 infection. Archives of Neurology, 53, 148–153.Google Scholar
Warner, M., Ernst, J., & Townes, B.D. (1987). Relationships between IQ and neuropsychological measures in neuropsychiatric populations: Within-laboratory and cross-cultural replications using WAIS and WAIS-R. Journal of Clinical and Experimental Neuropsychology, 9, 545–562.Google Scholar
Wilson, R., Li, Y., Aggarwal, N., Barnes, L., McCann, J., Gilley, D.W., & Evans, D.A. (2004). Education and the course of cognitive decline in Alzheimer disease. Neurology, 63, 1198–1202.Google Scholar